Michael Roth

Dr. Michael Roth is a Professor in the Department of Pediatrics at The University of Texas MD Anderson Cancer Center. He specializes in Pediatric Hematology/Oncology, having graduated from New York University School of Medicine and completing his residency and fellowship at Albert Einstein College of Medicine. His roles include Medical Director of the Survivorship Program and Director of the Childhood Cancer Survivorship Programs. Dr. Roth focuses on improving outcomes for adolescents and young adults (AYA) with cancer, emphasizing survivorship care, clinical trials, and addressing healthcare disparities. His research spans obesity management in cancer survivors, guideline-concordant treatment protocols, and disparities in access to care. He also leads initiatives to enhance patient-reported outcomes, fertility preservation, and symptom management in pediatric oncology. Dr. Roth’s work integrates clinical practice with translational research, aiming to optimize long-term health and quality of life for pediatric and AYA cancer patients.

Education & Training:

• M.D., New York University School of Medicine
• Pediatrics Residency, Albert Einstein College of Medicine
• Pediatric Hematology/Oncology Fellowship, Albert Einstein College of Medicine

Research Interests:

• Cancer survivorship care for AYA populations
• Optimizing clinical trial enrollment and adherence
• Health disparities in oncology care
• Chronic disease management post-cancer treatment

Key Themes in Published Work:

• AYA-specific outcomes in leukemia and lymphoma
• Impact of socioeconomic factors on treatment outcomes
• Role of patient-reported outcomes in clinical decision-making
• Innovative therapies for refractory leukemias

Clinical & Administrative Roles:

• Medical Director, Survivorship Program
• Director, Childhood Cancer Survivorship Programs
• Leadership in AYAHOP (Adolescent and Young Adult Hematology/Oncology Program)